Yes Rowdy................same situation with Resmed and may others........RMD was recommended as a buy/strong buy by every broker report I've seen on it...........all the way from $12 to $4.40 just recently. Just illustrates that most research houses should get a technical analyst who knows their stuff and that their methods (DCF etc........) often leave a lot to be desired.
Takes another hammering, page-4
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$288.75 |
Change
-0.750(0.26%) |
Mkt cap ! $139.3B | |||
| Open | High | Low | Value | Volume |
| $289.00 | $289.30 | $287.52 | $48.36M | 167.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 84 | $288.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $288.77 | 7 | 5 |
View Market Depth
| Last trade - 11.52am 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$288.91 |
Change
-0.750 ( 0.41 %) |
||||
| Open | High | Low | Volume | ||
| $289.01 | $289.19 | $287.51 | 3378 | ||
| Last updated 12.13pm 07/06/2024 ? | |||||
| CSL (ASX) Chart |